Analyze Diet
Theriogenology2026; 266; 118161; doi: 10.1016/j.theriogenology.2026.118161

hCG promotes secondary ovulation and supplementary corpus luteum formation during early pregnancy in mares.

Abstract: This study evaluated whether the administration of human chorionic gonadotropin (hCG) during early pregnancy accelerates ovulatory dynamics and alters serum progesterone concentrations in mares with dominant follicles. Thirty pregnant embryo-recipient mares with follicles ≥35 mm during early gestation were randomly assigned to receive either 1500 IU hCG IV (hCG group; n = 17) or saline solution IV (control group; n = 13). Mares were monitored by serial ultrasonography to determine the ovulatory response and the interval to secondary ovulation. Serum progesterone concentrations were analyzed using two complementary approaches: a chronological post-treatment analysis and an analysis synchronized with ovulation timing. The proportion of mares that ovulated within 48 h after treatment was significantly higher in the hCG group than in the control group (82.4% vs. 0%; P < 0.0001). Likewise, the interval between treatment and secondary ovulation was shorter in hCG-treated mares (median: 1.7 days; IQR: 1.6-1.8) than in control mares (median: 22 days; IQR: 20-23; P < 0.0001). The interval between primary and secondary ovulation was also shorter in hCG-treated mares (median: 38 days; IQR: 34-43) than in control mares (median: 54 days; IQR: 51-60; P = 0.0008). The chronological post-treatment analysis revealed a significant group × time interaction for serum progesterone concentrations (P < 0.0001). When the analysis was synchronized with ovulation timing, progesterone concentrations increased similarly over time in both groups (time effect: P < 0.0001), with no significant group × time interaction (P = 0.28). These findings demonstrate that dominant follicles present during early pregnancy remain responsive to exogenous gonadotropic stimulation, allowing secondary ovulation and, consequently, the formation of supplementary corpora lutea. Although hCG administration altered the temporal pattern of serum progesterone concentrations by accelerating ovulatory events, post-ovulation progesterone dynamics remained equivalent between groups when the analysis was synchronized with ovulation timing.
Publication Date: 2026-08-31 PubMed ID: 42679442DOI: 10.1016/j.theriogenology.2026.118161Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated whether administering human chorionic gonadotropin (hCG) to pregnant mares with large ovarian follicles during early pregnancy could induce earlier secondary ovulation and influence progesterone levels.
  • The research found that hCG significantly accelerated secondary ovulation and the formation of additional corpus luteum, although post-ovulation progesterone dynamics were similar when aligned with ovulation timing.

Study Objectives

  • To evaluate if hCG administration during early pregnancy can promote secondary ovulation in mares with dominant follicles (≥35 mm).
  • To assess whether hCG affects serum progesterone concentrations, which are vital for maintaining pregnancy.

Methodology

  • Subjects: 30 pregnant embryo-recipient mares displaying dominant follicles ≥35 mm early in gestation.
  • Groups: Mares randomly assigned to either:
    • hCG treatment group (1500 IU intravenously; n = 17)
    • Control group receiving saline solution intravenously (n = 13)
  • Monitoring: Serial ultrasonography used to observe ovulation timing and secondary ovulatory events.
  • Hormonal analysis: Serum progesterone measured using two approaches:
    • Chronological post-treatment analysis (measuring changes over time after treatment)
    • Analysis synchronized with the exact timing of ovulation to assess progesterone changes post-ovulation

Key Findings

  • Ovulation rates:
    • 82.4% of mares in the hCG group ovulated within 48 hours post-treatment, compared to 0% in the control group.
  • Timing differences:
    • Median interval from treatment to secondary ovulation was 1.7 days in hCG-treated mares versus 22 days in controls.
    • Interval between primary and secondary ovulation was also significantly shorter in hCG-treated mares (median 38 days) than controls (median 54 days).
  • Progesterone changes:
    • Using chronological post-treatment analysis, a significant interaction between treatment group and time was found, indicating that hCG altered progesterone levels over time.
    • When progesterone data was synchronized with the timing of ovulation, both groups showed similar increases, with no significant difference in progesterone dynamics post-ovulation.

Conclusions

  • Dominant follicles during early pregnancy in mares remain responsive to exogenous gonadotropic stimulation via hCG.
  • hCG administration effectively accelerates secondary ovulation, leading to the formation of supplementary corpora lutea, which are structures that produce progesterone to support pregnancy.
  • Although hCG changed the timing and pattern of serum progesterone concentration when viewed from treatment initiation, the overall progesterone profile following ovulation was comparable between treated and control mares.
  • These results highlight the potential for hCG to regulate ovarian function and support early pregnancy physiology in mares by inducing secondary ovulatory events and enhancing luteal function.

Cite This Article

APA
Campos DG, Araujo RR, Syllos I, Feltrin SR, Pereira IM, de Souza Rosa F, Dos Santos Amaral C, Portela VM, Antoniazzi AQ. (2026). hCG promotes secondary ovulation and supplementary corpus luteum formation during early pregnancy in mares. Theriogenology, 266, 118161. https://doi.org/10.1016/j.theriogenology.2026.118161

Publication

ISSN: 1879-3231
NlmUniqueID: 0421510
Country: United States
Language: English
Volume: 266
Pages: 118161
PII: S0093-691X(26)00351-1

Researcher Affiliations

Campos, Diego Guedes
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
Araujo, Reno Roldi
  • GeneTech Animal Reproduction, 13080-650, Brazil.
Syllos, Isabela
  • Department of Veterinary Pathological Anatomy, Federal Fluminense University (UFF), Niterói, RJ, 24220 900, Brazil.
Feltrin, Suzana Rossato
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
Pereira, Isadora Machado
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
de Souza Rosa, Fernanda
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
Dos Santos Amaral, Carolina
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
Portela, Valério Marques
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil.
Antoniazzi, Alfredo Quites
  • Laboratory of Biotechnology and Animal Reproduction (BioRep), Federal University of Santa Maria (UFSM), Santa Maria, RS, 97105-900, Brazil. Electronic address: alfredo.antoniazzi@ufsm.br.

MeSH Terms

  • Animals
  • Female
  • Chorionic Gonadotropin / pharmacology
  • Chorionic Gonadotropin / administration & dosage
  • Pregnancy
  • Horses / physiology
  • Ovulation / drug effects
  • Corpus Luteum / drug effects
  • Corpus Luteum / physiology
  • Progesterone / blood

Conflict of Interest Statement

Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Citations

This article has been cited 0 times.